How Does Sarcoidosis Affect African Americans?
At a Glance
African Americans, especially Black women, have a three times higher incidence of sarcoidosis and are more likely to experience severe, widespread forms of the disease. Managing it effectively requires specialized multidisciplinary care and proactive monitoring of the heart, eyes, and kidneys.
In this answer
4 sections
African Americans, particularly Black women, are significantly more likely to develop sarcoidosis than other racial groups and are at a higher risk for experiencing a more severe, widespread form of the disease [1][2]. The reasons for these differences are complex, involving a mix of genetics, environmental exposures (such as certain occupational dusts or chemicals), and systemic social factors [3][4]. Understanding how sarcoidosis affects the Black community is critical for advocating for early diagnosis, proactive monitoring, and highly specialized care.
Increased Risk and Incidence
In the United States, the incidence rate of sarcoidosis in African Americans is approximately three times higher than in white populations [1]. The disease also disproportionately affects Black women, who represent the highest-risk group for developing sarcoidosis and experiencing severe complications [2][5].
This disparity is not just about biology. While genetic variations related to African ancestry play a role, the way the disease develops and progresses is heavily influenced by social determinants of health—the conditions in the environments where people are born, live, learn, and work [3][4].
Differences in Disease Severity and Symptoms
Sarcoidosis is a multisystem disease, meaning it can cause inflammation and granulomas (clusters of inflammatory cells) in almost any organ [6]. While universal symptoms like a persistent cough, shortness of breath, and debilitating fatigue are major daily struggles for anyone with sarcoidosis, the disease is more likely to be widespread, severe, and chronic in Black patients [7]:
- Skin and Extrapulmonary Involvement: Black individuals are more likely to experience sarcoidosis outside the lungs (extrapulmonary sarcoidosis). Specifically, Black patients are more prone to certain specific variants of cutaneous (skin) sarcoidosis [8][9].
- Kidney Complications: Black women with sarcoidosis have an increased risk of developing nephrolithiasis (kidney stones) [10]. This requires proactive monitoring of calcium and vitamin D levels, as the granulomas can cause the body to improperly process calcium.
- Heart and Lung Differences: The clinical presentation of cardiac (heart) sarcoidosis and the patterns of pulmonary (lung) function impairment often differ in Black patients compared to other groups [11]. For example, there are significant differences in lung function impairment patterns by race, which can translate to more pronounced breathing difficulties [12].
Impact on Survival and Disparities in Care
While sarcoidosis is manageable for many people with the right care, statistics show that African American patients face higher risks for mortality compared to other demographic groups [5]. Black women, particularly those living in non-metropolitan or rural areas, are at the highest risk for sarcoidosis-associated mortality [2][13].
A major factor contributing to worse outcomes is inequity in the healthcare system. Research shows that Black patients experience significant delays in being referred to multidisciplinary Sarcoidosis Centers of Excellence compared to other racial groups [14]. Socioeconomic barriers, such as a lack of insurance and financial strain, also heavily influence disease progression and survival rates [15].
Advocating for Proactive, Specialized Care
Because sarcoidosis tends to be more severe and complex in African Americans, routine primary care is rarely sufficient. Achieving the best possible outcomes requires proactive and specialized management.
- Seek Specialized Care: If possible, ask your primary doctor for a referral to a recognized Sarcoidosis Center of Excellence (you can look for directories through organizations like the Foundation for Sarcoidosis Research or WASOG). These centers use multidisciplinary care models—bringing together lung, heart, eye, and skin specialists—that are better equipped to handle complex cases [16][14].
- Advocate for Comprehensive Baseline Screening: Because the disease can silently affect organs like the heart and eyes, you should receive baseline screenings (like an EKG, echocardiogram, and a thorough eye exam) even if you don’t have obvious symptoms in those areas [17][7].
- Monitor Calcium Levels: Discuss screening for calcium metabolism issues with your doctor to prevent kidney stones and other metabolic complications [10].
Advocating for yourself or your loved one means understanding these risks and partnering with doctors who have deep expertise in treating sarcoidosis in the Black community.
Common questions in this guide
Why are African Americans at a higher risk for severe sarcoidosis?
What symptoms of sarcoidosis are more common in Black patients?
Why do I need to monitor my calcium levels if I have sarcoidosis?
What is a Sarcoidosis Center of Excellence?
Why do I need heart and eye screenings if my sarcoidosis is in my lungs?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my risk factors, what is our timeline for conducting comprehensive baseline screenings for my heart and eyes?
- 2.How will we monitor my calcium and vitamin D levels to protect my kidneys while managing my sarcoidosis?
- 3.Are you experienced in treating systemic sarcoidosis in Black patients, or should we discuss a referral to a specialized Sarcoidosis Center of Excellence?
- 4.My cough and fatigue heavily impact my daily life; what long-term management strategies can we use if my condition becomes chronic?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (17)
- 1
Hepatic Sarcoidosis: Incidence, Monitoring, and Treatment.
Ryland KL
Clinical liver disease 2020; (16(5)):208-211 doi:10.1002/cld.1002.
PMID: 33318790 - 2
Shifting temporal trends and disparities in sarcoidosis mortality in the United States: A retrospective analysis from 1999 to 2020.
Raza FA, Kumar S, Mohammad A, et al.
PloS one 2025; (20(1)):e0317237 doi:10.1371/journal.pone.0317237.
PMID: 39792876 - 3
Identification of Environmental Exposures Associated with Risk of Sarcoidosis in African Americans.
Levin AM, She R, Chen Y, et al.
Annals of the American Thoracic Society 2023; (20(9)):1274-1282 doi:10.1513/AnnalsATS.202208-722OC.
PMID: 37209419 - 4
Genetics and Social Determinants of Health as Drivers of Epidemiologic Variation in Sarcoidosis.
Odackal J, Crouser ED, Sharp M, Cozier YC
Seminars in respiratory and critical care medicine 2025; (46(6)):602-607 doi:10.1055/a-2724-5501.
PMID: 41130282 - 5
Acthar Gel in African Americans versus Non-African Americans with Symptomatic Sarcoidosis: Physician Assessment of Patient Medical Records.
Bindra J, Chopra I, Hayes K, et al.
Therapeutics and clinical risk management 2024; (20()):83-94 doi:10.2147/TCRM.S438174.
PMID: 38351954 - 6
Extrapulmonary sarcoidosis in an atypical patient demographic.
Modi T, Maniam G, Quirch M, et al.
Proceedings (Baylor University. Medical Center) 2020; (34(1)):151-152 doi:10.1080/08998280.2020.1824963.
PMID: 33456182 - 7
Systemic Associations of Sarcoid Uveitis: Correlation With Uveitis Phenotype and Ethnicity.
Niederer RL, Ma SP, Wilsher ML, et al.
American journal of ophthalmology 2021; (229()):169-175 doi:10.1016/j.ajo.2021.03.003.
PMID: 33737030 - 8
A Rare Case of Sarcoidosis Presenting With Cutaneous Medium-Vessel Granulomatous Vasculitis Treated With Rituximab.
Dalia T, Liu D, Fraga GR, Springer J
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2021; (27(6)):e221-e225 doi:10.1097/RHU.0000000000000941.
PMID: 30586000 - 9
Ichthyosiform sarcoidosis and systemic involvement.
Patel K, Lyon M, Hernandez C
Cutis 2018; (102(6)):408-410.
PMID: 30657799 - 10
Sarcoidosis and Risk of Nephrolithiasis in US Black Women: Data from the Black Women's Health Study.
McAllister TR, Govender P, Hicks JM, et al.
CHEST pulmonary 2025; (3(4)) doi:10.1016/j.chpulm.2025.100193.
PMID: 41646626 - 11
Sex and Race Differences in Cardiac Sarcoidosis Presentation, Treatment and Outcomes.
Duvall C, Pavlovic N, Rosen NS, et al.
Journal of cardiac failure 2023; (29(8)):1135-1145 doi:10.1016/j.cardfail.2023.03.022.
PMID: 37062472 - 12
Heterogeneity of Lung Function Phenotypes in Sarcoidosis: Role of Race and Sex Differences.
Sharp M, Psoter KJ, Balasubramanian A, et al.
Annals of the American Thoracic Society 2023; (20(1)):30-37 doi:10.1513/AnnalsATS.202204-328OC.
PMID: 35926103 - 13
Disparities in Sarcoidosis Mortality by Region, Urbanization, and Race in the United States: A Multiple Cause of Death Analysis.
Ogundipe F, Mehari A, Gillum R
The American journal of medicine 2019; (132(9)):1062-1068.e3 doi:10.1016/j.amjmed.2019.03.048.
PMID: 31047868 - 14
Delays in Referral to Multidisciplinary Care for Black Individuals With Sarcoidosis.
Mathias KR, Akhiwu O, Mustafa AM, et al.
CHEST pulmonary 2025; (3(2)) doi:10.1016/j.chpulm.2024.100125.
PMID: 40918541 - 15
Sarcoidosis Epidemiology: Race Matters.
Hena KM
Frontiers in immunology 2020; (11()):537382 doi:10.3389/fimmu.2020.537382.
PMID: 33042137 - 16
TEAM Sarcoidosis: Creating a Multidisciplinary Care Team for Complex Clinical Management.
Mathias KR, Mustafa AM, Nyakinye KJ, et al.
Chest 2026; (169(5)):1279-1285 doi:10.1016/j.chest.2025.11.037.
PMID: 41380938 - 17
Diagnostic Value of Comprehensive Echocardiographic Assessment Including Speckle-Tracking in Patients with Sarcoidosis Versus Healthy Controls: A Systematic Review and Meta-Analysis.
Jain H, Shahzad M, Ahsan M, et al.
Diagnostics (Basel, Switzerland) 2025; (15(6)) doi:10.3390/diagnostics15060708.
PMID: 40150051
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor or a specialized Sarcoidosis Center of Excellence for personalized care and monitoring.
Get notified when new evidence is published on Sarcoidosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.